Preparation process of nitroguanidine derivatives
    3.
    发明授权
    Preparation process of nitroguanidine derivatives 失效
    硝基胍衍生物的制备方法

    公开(公告)号:US6118007A

    公开(公告)日:2000-09-12

    申请号:US46588

    申请日:1998-03-24

    CPC classification number: C07D277/32 C07D407/06 C07D417/06

    Abstract: A process, as a substitute for hydrolysis, for preparing a nitroguanidine derivative represented by the following formula (2): ##STR1## wherein A represents a substituted or unsubstituted aromatic or non-aromatic hydrocarbon ring, a substituted or unsubstituted aromatic or non-aromatic heterocycle, a hydrogen atom or a substituted or unsubstituted alkyl, alkenyl or alkynyl group; and R.sub.2 represents a hydrogen atom, a substituted or unsubstituted C.sub.1-6 alkyl, alkenyl or alkynyl group, which comprises reacting a compound represented by the following formula (1): ##STR2## wherein R.sub.1 represents a substituted or unsubstituted, linear or cyclic C.sub.1-10 alkyl group and A and R.sub.2 have the same meanings as defined above, with ammonia, a primary amine or a secondary amine, or a salt thereof.

    Abstract translation: 用于制备由下式(2)表示的硝基胍衍生物的方法作为水解的替代方法:其中A表示取代或未取代的芳族或非芳族烃环,取代或未取代的芳族或非芳族杂环, 氢原子或取代或未取代的烷基,烯基或炔基; R 2表示氢原子,取代或未取代的C 1-6烷基,烯基或炔基,其包括使下式(1)表示的化合物:其中R 1表示取代或未取代的直链或环状C 1-10烷基 基团和A和R 2具有与上述相同的含义,与氨,伯胺或仲胺或其盐。

    Isoquinoline derivatives
    4.
    发明授权
    Isoquinoline derivatives 失效
    异喹啉衍生物

    公开(公告)号:US4782154A

    公开(公告)日:1988-11-01

    申请号:US75828

    申请日:1987-07-17

    CPC classification number: C07D401/04

    Abstract: The isoquinoline derivatives represented by the following general formula (I) are useful as cardiotonics having high cardiotonic activity and low toxicity: ##STR1## where R.sub.1 represents a lower C.sub.1 -C.sub.4 alkyl group or cyclopropyl group,R.sub.2 represents formyl group, lower C.sub.1 -C.sub.4 alkanoyl group and benzoyl group, lower C.sub.1 -C.sub.4 alkyl group, lower C.sub.1 -C.sub.4 alkenyl group, lower C.sub.1 -C.sub.4 hydroxy substituted alkyl group, C.sub.1 -C.sub.4 perfluoroalkyl group andR.sub.3 represents 4-pyridyl group or 2-pyridyl group respectively,and the therapeutically acceptable salts thereof are also useful as cardiotonics.

    Abstract translation: 由以下通式(I)表示的异喹啉衍生物可用作具有高强度活性和低毒性的强心剂:其中R 1表示低级C 1 -C 4烷基或环丙基,R 2表示甲酰基,低级 C1-C4烷酰基和苯甲酰基,低级C1-C4烷基,低级C1-C4烯基,低级C1-C4羟基取代烷基,C1-C4全氟烷基,R3分别代表4-吡啶基或2-吡啶基 ,其治疗上可接受的盐也可用作强心剂。

    Process for preparing 4-acetyl isoquinolinone compounds
    6.
    发明授权
    Process for preparing 4-acetyl isoquinolinone compounds 失效
    制备4-乙酰基异喹啉酮化合物的方法

    公开(公告)号:US4814458A

    公开(公告)日:1989-03-21

    申请号:US10304

    申请日:1987-02-02

    CPC classification number: C07D401/04

    Abstract: This invention relates to a novel process for preparing 4-acetyl-1-methyl-7-pyridyl-5,6,7,8-tetrahydro-3(2H)-isoquinolinone characterized by condensing 2-acetyl-4-pyridyl cyclohexanone with acetoacetamide. This compound is useful as pharmaceuticals, particularly cardiotonics.

    Abstract translation: 本发明涉及一种制备4-乙酰基-1-甲基-7-吡啶基-5,6,7,8-四氢-3(2H) - 异喹啉酮的新方法,其特征在于将2-乙酰基-4-吡啶基环己酮与乙酰乙酰胺 。 该化合物可用作药物,特别是强心剂。

Patent Agency Ranking